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Summary
The biosynthetic gene cluster for chlorothricin (CHL)
was localized to a 122 kb contiguous DNA from Strep-
tomyces antibioticus DSM 40725, and its involvement
in CHL biosynthesis was confirmed by gene inactiva-
tion and complementation. Bioinformatic analysis of
the sequenced 111.989 kb DNA region revealed 42
open reading frames, 35 of which were defined to
constitute the CHL gene cluster. An assembly model
for CHL biosynthesis from D-olivose, 2-methoxy-5-
chloro-6-methylsalicyclic acid, and chlorothricolide
building blocks was proposed. This work represents
cloning of a gene cluster for spirotetronate antibiotic
biosynthesis and sets the stage to investigate the
unusual macrolide biosynthesis including tandem
Diels-Alder cyclizations, Baeyer-Villiger oxidation, and
incorporation of an enoylpyruvate unit.
Introduction
The spirotetronate antibiotics are a class of natural
products that exhibit broad biological activities, includ-
ing antibacteria, antitumor, antimalaria, and cholesterol
biosynthesis inhibition [1–4]. They feature an unusual
aglycone that contains a characteristic tetronic acid
(spiro-linked to a cyclohexene ring) conjugated with
a trans-decalin system either by a carboxylic ester,
such as chlorothricin (CHL), or by a carbonyl group,
such as kijanimicin (KIJ) or tetrocarcin A (TC-A) (Fig-
ure 1). Further decoration of the structurally related agly-
cones with a variety of deoxysugar and/or other periph-
eral moieties renders the diversity of structures and
activities of members in this family.
Although most of the spirotetronate antibiotics pos-
sess moderate activity against gram-positive bacteria,
CHL is the only member whose mechanism of action
was demonstrated to inhibit pyruvate carboxylase,
which catalyzes the anaplerotic CO2 fixation on syn-
thetic media [5]. Later screening of the microbial com-
*Correspondence: gltang@mail.sioc.ac.cn (G.-L.T.); wliu@mail.sioc.
ac.cn (W.L.)pounds indicated that CHL and its derivatives inhibit
cholesterol biosynthesis via the mevalonate pathway
[4]. KIJ is active in vitro against an unusual range of mi-
croorganisms (including some anaerobic bacteria), and
studies in vivo have shown that it also has antimalarial
activity [2]. TC-A exhibits remarkable activities against
various experimental tumor models, but it has no signif-
icant myelosuppression and nephrotoxocity in mice [6].
Recently, studies of effects on T-acute lymphoblastic
leukemia (T-ALL) and B-chronic lymphocytic leukemia
(B-CLL) suggest that TC-A induces apoptosis by a novel
signal transduction pathway and might represent an at-
tractive lead for further antitumor drug development [7,
8]. The extensive investigation of the structure-activity
relationships relied entirely on the semisynthesis from
the available natural products [9], and alterations of
the macrolide backbones have not yet been explored,
probably in part because of the structural complexity.
CHL, isolated from Streptomyces antibioticus Tu¨99
(deposited in DSMZ with the accession number DSM
40725) in 1969 [1], was the first member of the spirotetr-
onate family to be structurally elucidated. The structure
of chlorothricolide (the aglycone of CHL) was originally
elucidated by using spectroscopic methods and degra-
dation experiments [10] and was ultimately confirmed
by single-crystal X-ray analysis [11]. Thereafter, chloro-
thricolide, as a molecular model of the spirotetronate
macrolides, has stimulated considerable efforts for its
total synthesis [12, 13].
While great success has been achieved in the chemi-
cal synthesis of CHL and spirotetronates, the biosyn-
thetic studies on spirotetronate natural products are still
limited. Previous feeding experiments examining CHL
biosynthesis showed that the backbones of 2-me-
thoxy-5-chloro-6-methylsalicyclic acid and chlorothri-
colide (with the exception of C-22, -23, and -24; Figure 1)
are likely of polyketide origin, and that the two deoxysu-
gar (D-olivose) moieties derive from glucose [14–16].
Here, we report the cloning and sequencing of the CHL
biosynthetic gene cluster from S. antibioticus DSM
40725, and the functions of the deduced gene products
are proposed. Sequence analyses revealed a pathway
for the biosynthesis of the characteristic macrolide agly-
cone and supported an assembly model for CHL biosyn-
thesis from D-olivose, 2-methoxy-5-chloro-6-methylsa-
licyclic acid, and chlorothricolide building blocks. To
our knowledge, this study represents the first cloning
of a gene cluster for spirotetronate antibiotic biosynthe-
sis. The findings set the stage to investigate the genetic
and biochemical basis for CHL biosynthesis and make
it possible to generate structural diversity for drug dis-
covery and development by applying combinatorial bio-
synthesis to the CHL biosynthetic machinery.
Results and Discussion
Cloning and Identification of the CHL Gene Cluster
from S. antibioticus DSM 40725
It has been well established that most deoxysugars derive
from the common intermediate 4-keto-6-deoxyglucose
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576Figure 1. Structures of Chlorothricin, Deschloro-Chlorothricin, Desmethylsalicycloyl Chlorothricin, Kijanimicin, and Tetrocarcin Anucleoside diphosphate, the biosynthesis of which orig-
inates from glucose nucleoside diphosphate and is cat-
alyzed by a conserved NAD+-dependent oxidoreduc-
tase (dNDP-D-glucose-4,6-dehydratase, NGDH) [17].
Using PCR and Southern hybridization approaches,
Sohng and coworkers identified at least three putative
NGDH genes from the genomic DNA of the CHL pro-
ducer S. antibioticus Tu¨99 [18], and one of those, oxiIII,
was suggested to be involved in the CHL deoxysugar
biosynthesis due to the fact that oxiIII is adjacent to
a partial type I PKS gene [19]. As a result, we utilized
the oxiIII sequence and cloned a 550 bp internal
fragment of oxiIII by PCR. However, inactivation of the
cloned NGDH gene resulted in the mutant strain
TL1001 that retains the ability of CHL production (Fig-
ure 2, II), excluding its involvement in CHL biosynthesis.Since the feeding experiment by incorporation of iso-
tope-labeled acetate and propionate into the CHL agyl-
cone supported its polyketide origin [15], we adopted
a strategy to clone the putative chlorothricolide PKS
genes by PCR with degenerate primers designed ac-
cording to the highly conserved motifs of type I PKSs
(described in Experimental Procedures). A single band
with the predicted size of 750 bp was amplified and
cloned into pGEM-T easy vector (Table S1; see the Sup-
plemental Data available with this article online). By di-
gestion with various restriction enzymes, eight resultant
clones were classified into two distinct groups (repre-
sented by pTL1023 and pTL1024, respectively), both of
which were shown to be highly homologous to known
type I PKS genes based on sequence analysis. To deter-
mine whether these putative PKS genes are required forFigure 2. HPLC Analysis of CHL Production by S. antibioticus Wild-Type and Recombinant Strains
(I) An authentic standard, (II) TL1001 (DNGDH), (III) TL1002 (DPKS-P1), (IV) TL1003 (DPKS-P2), (V) TL1006 (DchlD3), (VI) TL1010 (chlD3:ermE*),
(VII) wild-type, (VIII) TL1005 (DchlC7), (IX) TL1009 (chlC7:ermE*), (X) TL1007 (DchlD4), (XI) TL1011 (chlD4:ermE*), and (XII) TL1004 (Dorf(-1)). The
asterisk and dark dot indicate CHL and Deschloro-CHL, respectively.
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577Figure 3. Restriction Map and Genetic Organization of the CHL Biosynthetic Gene Cluster
(A) Restriction map of the 122 kb DNA region from S. antibioticus DSM 40725 as represented by seven overlapping cosmid clones. ‘‘B,’’
BamHI. Solid black bars indicate the sequenced DNA region; solid quadrates indicate the probe loci.
(B) Genetic organization of the CHL biosynthetic gene cluster. Proposed functions of individual orfs are shade coded and summarized in Table 1.CHL biosynthesis, we set out to inactivate their target
alleles and found that the resultant mutants, TL1002
and TL1003, completely lost the ability to produce CHL
(Figure 2, III and IV), unambiguously confirming their
involvement in CHL biosynthesis. Subsequently, the di-
goxigenin-(DIG)-labeled PCR product P1 from pTL1023
was utilized as a probe to screen approximately 6,000
clones of the genomic library, resulting in the isolation
of a set of overlapping cosmids spanning 70 kb. Further
Southern hybridization with the DIG-labeled PCR prod-
uct P2 from pTL1024 indicated that both P1 and P2 are
closely linked within a DNA region of approximately 15
kb (Figure 3A).
In addition, a novel iterative PKS gene, chlB1, for 6-
methylsalicyclic acid biosynthesis was cloned by PCR
with the degenerate primer pairC-D designed according
to the conserved motifs that are unique to iterative type I
PKSs (L.S. et al., unpublished data). Consistent with the
fact that genes for antibiotic production are commonly
clustered in one region of the chromosome in Actinomy-
cetes, the PCR product of chlB1was localized to a single5.1 kb BamHI fragment that is w25 kb upstream of the
P2 locus. Taken together, these results provided strong
support that the CHL gene cluster in S. antibioticusDSM
40725 was cloned. To ensure full coverage of the entire
CHL cluster, we carried out additional chromosomal
walking from the chlB1 locus (P3, a 0.9 kb PCR product
of chlB1 amplified with the primer pair C-D) and the right
end of pTL1504 (P4, a 0.5 kb PCR product), and we
eventually identified a 122 kb contiguous DNA region
of overlapping cosmids, as exemplified by pTL1501,
pTL1502, pTL1503, pTL1504, pTL1505, pTL1506, and
pTL1507 (Figure 3A).
Sequence Analysis and Gene Organization
of the CHL Cluster
The DNA region represented by three overlapping cos-
mids, pTL1502, pTL1504, and pTL1507, was selected
for shotgun DNA sequencing, yielding 111,989 bp of con-
tiguous sequence. The overall GC content of the se-
quenced region is 71.8%, characteristic ofStreptomyces
DNA. Bioinformatic analysis (described in Experimental
Chemistry & Biology
578Table 1. Deduced Functions of orfs in the CHL Biosynthetic Gene Cluster
Gene Sizea Protein, Homolog,b and Origin
Similarity/
Identity, % Proposed Function
orf(-3)c 222 YHJG (NP_266946); Lactococcus lactis subsp. 47/29 Acetyl transferase
orf(-2)c 136 — — Unknown protein
orf(-1)c 206 DVU2436 (YP_011649); Desulfovibrio vulgaris
subsp.
60/51 Predicted hydrolases of the HD superfamily
orf(0)c 246 PF01526 (BAC68130); S. avermitilis MA-4680 74/65 Transposase
chlC7 411 CmmGIII (CAE17545); S. griseus subsp. griseus 54/42 Glycosyltransferase
chlB1 1756 AviM (AAK83194); S. viridochromogenes 70/58 Type I PKS: KS-AT-KR-DH-ACP
chlB4 449 PltA (AAQ90172); Pseudomonas sp. M18 77/62 Halogenase
chlB2 88 CouN5 (AAG29790); S. rishiriensis 67/38 Discrete ACP
chlB3 347 AviN (AAK83178); S. viridochromogenes 64/49 Ketoacyl-ACP synthase, condensing protein
chlH 137 — — Unknown protein
chlB5 238 COG4122 (ZP_00343262); Desulfitobacterium
hafniense DCB-2
61/48 O-methyltransferase
chlB6 352 CalO4 (AAM70354); Micromonospora
echinospora
51/37 Ketoacyl-ACP synthase, condensing protein
chlC5 247 LanR (AAD13548); S. cyanogenus 64/50 4-Ketoreductase
chlC4 331 AknQ (AAF73453); S. galilaeus 63/53 3-Ketoreductase
chlC3 438 ORF18 (AAG52988); Amycolatopsis mediterranei 63/51 2,3-Dehydratase
chlI 70 simX2 (AAK06794); S. antibioticus 58/51 Coupling protein of carboxyl transferase
chlJ 535 SCO5535 (CAA19983); S. coelicolor A3(2) 95/91 Carboxyl transferase
chlF1 202 TetR family (YP_103523); Burkholderia
pseudomallei K96243
53/37 Transcriptional regulator
chlG 488 SCO1194 (CAB61606); S. coelicolor A3(2) 57/40 Export protein
chlF2 261 MonRI (AAO65809); S. cinnamonensis 84/75 Response regulator of 2-component system
chlK 266 MonAX (AAO65810); S. cinnamonensis 73/63 Type II TE
chlC2 327 Med-ORF17 (BAC79030)S. sp. AM-7161 77/64 dNDP-glucose-4,6-dehydratase
chlC1 355 CmmD (CAE17529); S. griseus subsp. griseus 71/56 dNDP-glucose synthase
chlC6 404 CmmGIII (CAE17545); S. griseus subsp. griseus 53/40 Glycosyltransferase
chlE1 516 CmmOIV (CAE17536); S. griseus subsp. griseus 58/46 FAD-dependent oxygenase
chlA1 4699 SCO6275 (CAD55506); S. coelicolor A3(2) 62/52 Type I PKS: KSQ-AT-ACP-KS-AT-DH-KR-ACP-
KS-AT-DH-KR-ACP
chlA2 3955 Orf16 (AAX98191); S. aizunensis 66/54 Type I PKS: KS-AT-DH-KR-ACP-KS-AT-DH-ER-
KR-ACP
chlE2 398 Cyp234 (AAT45294); S. tubercidicus 57/44 Cytochrome P-450 hydroxylase
chlA3 5718 Orf16 (AAX98191); S. aizunensis 65/53 Type I PKS: KS-AT-DH-ER-KR-ACP-KS-AT-DH-
KR-ACP-KS-AT-DH-KR-ACP
chlA4 1853 Orf13 (AAX98188); S. aizunensis 63/52 Type I PKS: KS-AT-DHc-KR-ACP
chlA5 3936 Orf16 (AAX98191); S. aizunensis 66/54 Type I PKS: KS-AT-DH-ER-KR-ACP KS-AT-DH-
KR-ACP
chlA6 1583 Orf13 (AAX98188); S. aizunensis 61/49 Type I PKS: KS-AT-ACP
chlE3 498 CmmOIV (CAE17536); S. griseus subsp. griseus 53/42 FAD-dependent oxygenase
chlL 191 LSU (YP_190800); Gluconobacter oxydans 621H 44/31 Ribosomal protein L15P
chlM 375 COG0332 (ZP_00110099); Nostoc punctiforme
PCC 73102
65/45 3-Oxoacyl-ACP synthase III
chlD1 651 FkbH (AAF86387); S. hygroscopicus var.
ascomyceticus
44/31 Involved in glycerol-S-ACP biosynthesis
chlD2 75 COG0236 (ZP_00110101); Nostoc punctiforme
PCC 73102
62/40 Acyl carrier protein
chlD3 271 COG0508 (ZP_00110102); Nostoc punctiforme
PCC 73102
65/44 Pyruvate/2-oxoglutarate dehydrogenase/
dehydratase
chlD4 362 COG0596 (ZP_00110109); Nostoc punctiforme
PCC 73102
59/38 Predicted hydrolases or acyltransferases
orf36c 131 COG0624 (ZP_00134467); Actinobacillus
leuropneumoniae serovar 1 str. 4074
46/36 Unknown protein, similar to acetylornithine
deacetylase
orf37c 813 SCP1.136 (CAC36657); S. coelicolor A3(2) 44/31 Putative helicase
orf38c 374 ANK (EAP00483); Marinobacter aquaeolei VT8 37/50 Ankyrin repeat
orf39c 168 TAB182 (AAM15531); Homo sapiens 29/40 Tankyrase1-binding protein
a Numbers are in amino acids.
b NCBI accession numbers are given in parentheses.
corfs beyond the CHL gene cluster.Procedures) revealed 42 open reading frames (orfs),
and individual orfs were functionally assigned by
comparison to proteins of known functions in the data-
base (shown in Figure 3B; summarized in Table 1). The
GenBank accession number for the CHL cluster is
DQ116941.Determination of the CHL Gene Cluster Boundaries
To determine the boundaries of the CHL gene cluster,
we inactivated a series of orfs by gene disruption or re-
placement within the sequenced region. Inactivation of
chlD3, chlD4, and chlC7 completely abolished CHL pro-
duction (Figure 2, V, X, and VIII), confirming that they are
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of orf(-1) had no effect on CHL production (Figure 2,
XII), clearly indicating that its locus resides outside the
chl cluster. Several attempts to inactivate orf36 and
orf37 resulted in non-CHL-producing mutants whose
genotypes did not match the predicted patterns based
on Southern hybridization analysis (data not shown).
Sequence analysis revealed that orf37 encodes an 813
aa putative helicase, and a 1203 bp noncoding region
between orf36 and orf37 exists, suggesting that orf37
and its flanking noncoding region are outside of the
chl cluster but may be indispensable for the replication
of an extrachromosomal plasmid, and genetic manipu-
lation at the adjacent orf36 locus may affect its stability.
This prediction is consistent with our recent evidence
that the CHL gene cluster is carried on a linear plasmid
(data not shown). We prefer the possibility that orf36 is
outside of the CHL gene cluster for two reasons: first,
in addition to orf37, orf38, and orf39, orf36 lacks signif-
icant similarity to genes involved in secondary metabo-
lite biosynthesis; and second, the failure of generating
an orf36 mutant suggests that it may not be a ‘‘real’’
gene and that its putative coding region may function
in cis for replication. These results, together with the
functional assignment of deduced gene products within
the sequenced region, support the conclusion that the
CHL gene cluster is minimally contained within the re-
gion from chlC7 to chlD4, which spans 101.8 kb and en-
compasses 35 orfs. Therefore, establishment of the
boundaries of the CHL gene cluster provided a basis
to predict the CHL biosynthetic pathway.
Regulation and Self-Resistance
of CHL Biosynthesis
Two putative regulatory genes, chlF1 and chlF2, are
identified, and the deduced functions would agree with
their roles as pathway-specific regulators involved in
CHL biosynthesis. While ChlF1 belongs to a TetR regu-
latory protein family, ChlF2 contains a putative effector
domain of response regulators, suggesting that it is
a member of a two-component system that could detect
and respond to changes in the environment, and eventu-
ally control the CHL biosynthesis. Only one putative re-
sistance gene, chlG, is found in the CHL cluster. The
deduced protein of chlG is homologous to members of
a general family of transporters. Since most of the CHL
is extracted from the ultrasonic-fragmented mycelia,
ChlG may not be efficient to transport the synthesized
product out of the cells.
Biosynthesis of the Deoxysugar Moiety
2,6-Dideoxysugars are frequently found to be the vital
components in secondary metabolites [20]. In the past
decades, a number of genes involved in their biosynthe-
ses have been cloned and extensively investigated [21].
Seven genes, chlC1–chlC7, are identified in the CHL
gene cluster and encode proteins that are homologous
to enzymes for D-olivose biosynthesis, the pathway of
which has been well established in mithramycin [22],
chromomycin [23], urdamycin [24], and landomycin
[25] producers, indicating that a similar strategy is uti-
lized in the biosynthesis of the CHL deoxysugar moiety,
as outlined in Figure 4A.The deduced product of chlC1 resembles a member
of the family of dNDP-glucose synthases, consistent
with the feeding experiment that established incorpora-
tion of isotope-labeled glucose into the CHL deoxysugar
moiety. After dNDP activation of glucose, ChlC2, closely
related to members of the NGDH family, assumedly cat-
alyzes the formation of dNDP-4-keto-6-deoxyhexose
(1). ChlC3, highly homologous to dNDP-hexose dehy-
dratases that catalyze 2,3-dehydration to form a,b-un-
saturated 4-ketosugar, together with ChlC4, similar to
3-ketoreductases that render a hydroxyl group at C-3
with an equatorial configuration, is likely involved in
the C-2 deoxygenation step, forming dNDP-4-keto-
2,6-hexose (2). ChlC5, a putative 4-ketoreductase, may
reduce the keto group at C-4, leading to the formation
of dNDP-olivose (3). Both ChlC6 and ChlC7, resembling
a family of glycosyl transferases, are presumably re-
sponsible for tandemly transferring two dexoysugar
moieties to the CHL aglycone. The chlC7 mutant strain
TL1005 completely lost its ability to produce CHL (Fig-
ure 2, VIII), which was then restored by expressing
chlC7 in trans under the control of the ermE* promoter
(TL1009, Figure 2, IX), confirming its involvement in
CHL biosynthesis.
Biosynthesis of the 2-Methoxy-5-Chloro-6-
Methylsalicyclic Acid Moiety
Six genes, chlB1–chlB6, are identified within the CHL
cluster, and according to their deduced functions, the
biosynthetic pathway of 2-methoxy-5-chloro-6-methyl-
salicyclic acid is established as outlined in Figure 4B.
The deduced product of chlB1 has the characteristic
type I PKS domains, including a ketosynthase (KS), acyl-
transferase (AT), dehydratase (DH), ketoreductase (KR),
and acyl carrier protein (ACP). Although it is well known
that aromatic polyketide biosyntheses are catalyzed by
iterative type I PKSs in fungi [26], a similar paradigm in
bacteria in the biosyntheses of orsellinic acid and naph-
thoic acid has been undescribed until recently [27].
ChlB1 exhibits head-to-tail homology to NcsB that cata-
lyzes the naphthoic acid biosynthesis for neocarzinosta-
tin in S. carzinostaticus [28], and to AviM and CalO5 (ex-
cluding the KR domain), both of which catalyze orsellinic
acid biosynthesis for avilamycin in S. viridochromo-
genes [29] and calicheamicin in Micromonospora echi-
nospora [30]. In a mechanistic analogy, ChlB1 (as AviM
or CalO5) could catalyze the assembly of a nascent lin-
ear tetraketide (4) from one acetyl-coenzyme A (CoA)
and three malonyl-CoAs, and the additional KR domains
of ChlB1 (the similar domain was found in NcsB) may of-
fer a selective activity of keto reduction at the C-5 posi-
tion. The resultant unsaturated intermediate undergoes
an intramolecular aldol condensation to furnish the
6-methylsalicyclic acid (5) structure. Subsequently,
ChlB5, a member of the SAM-dependent methyltrans-
ferase family, and ChlB4, a homolog of the halogenase
family, are presumably responsible for C-2 O-methyla-
tion and C-5 chlorination to afford the fully modified
methylsalicyclic acid moiety (7). This deduced biosyn-
thetic pathway is consistent with the isotope-labeled
feeding experiments that showed 2-methoxy-5-chloro-
6-methylsalicyclic acid containing four head-to-tail ace-
tates and an O-methyl group from S-adenosyl-L-methi-
onine (SAM) [14, 15].
Chemistry & Biology
580Figure 4. Proposed Biosynthetic Pathways
(A–D) Pathways for (A) deoxysugar olivose, (B) 2-methoxy-5-chloro-6 methylsalicyclic acid, (C) 3-carbon unit enoylpyruvate, and (D) chlorothri-
colide. A model for the assembly of CHL is also shown.To confirm the role of ChlB1, we inactivated chlB1 by
replacing it with the apramycin resistance gene,aac(3)IV.
As shown in Figures 5A and 5B (III), the resultant mutant
strain TL1012 produces a compound that is biologically
active but distinct from CHL upon HPLC analysis. The re-
sulting compound was isolated and subjected to LC-MS
analysis, exhibiting an (M-H)2 ion at m/z = 771.3, consis-
tent with the molecular formula C41H56O14. By compari-
son with CHL, it was proposed to be demethylsalicycloyl
CHL (DM-CHL) that lacks the entire modified methylsali-
cyclic acid moiety. The deduced conclusion was further
confirmed by HR-MS and NMR spectra analyses (de-
tailed data are summarized in Supplemental Data). Intro-
duction of chlB1 into the mutant strain TL1012 led to the
recombinant strain TL1013 (Figure 5B, IV), in which thecompound DM-CHL was converted into CHL (purified
by HPLC and confirmed by LC-MS, data not shown).
These results, together with the above-described
functional assignments of ChlB4 as a halogenase and
ChlB5 as an O-methyltransferase, respectively, support
the conclusion that ChlB1 acts as a 6-methylsalicyclic
acid synthase in the biosynthetic pathway of 2-me-
thoxy-5-chloro-6-methylsalicyclic acid.
A pair of genes, chlB2 and chlB3, that are just up-
stream of chlB4, encode a putative discrete ACP protein
and b-ketoacyl-ACP synthase, respectively. Since the
covalent tethering as the acyl-S-ACP (or PCP) is a com-
mon strategy to sequester the substrate and provide
a platform for further decoration in many biosynthetic
pathways of secondary metabolites, we propose that
Chlorothricin Biosynthetic Gene Cluster
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CHL and DM-CHL
(A) Determination of antibacterial activities of
CHL and DM-CHL against B. subtilis. Each
sample was dissolved in 10 ml methanol and
then added to the round filter paper. (1) 10 ml
methanol (negative control), (2) 10 mg CHL,
(3) 1 mg CHL, (4) 10 mg DM-CHL, and (5) 1 mg
DM-CHL.
(B) HPLC analysis of CHL or DM-CHL produc-
tion. (I) S. antibioticus DSM 40725, (II) TL1008
(DchlB6), (III) TL1012 (DchlB1), and (IV)
TL1013 (chlB1:ermE*). The asterisk and trian-
gle indicate CHL and DM-CHL, respectively.6-methysalicyclic acid could be activated by ChlB3 and
then transferred to ChlB2. In other words, the methyl-
salicycloyl-S-ACP (6) is presumably formed before
methylation and chlorination. ChlB6, a putative con-
densing protein, may catalyze the attachment of the
methylsalicycloyl group to the glycosidically linked
olivoses. It should be noted that ChlB3 and ChlB6 are
highly homologous to AviN and CalO4 [29, 30], both of
which could be required for transferring the orsellinic
acid moiety to the deoxysugar. Although it remains to
be established whether the free acid or acyl-S-ACP is
the preferred substrate for AviN or CalO4, our functional
assignments of ChlB3 and ChlB6 based on gene organi-
zation and sequence comparison indicate their differen-
tiation of function evolution and suggest that formation
of the activated substrates as acyl-S-ACP might be
a common way in which the last attachment step occurs.
To validate the hypothesis that chlB6 is essential for
CHL biosynthesis, we inactivated chlB6 by gene disrup-
tion and constructed the mutant strain TL1008. Conse-
quently, TL1008 produces the same compound, DM-
CHL, as the DchlB1 mutant strain TL1012 upon HPLC
and LC-MS analyses (Figure 5B, II).These results sup-
port the functional assignment of ChlB6 and demon-
strate the feasibility to genetically manipulate the CHL
machinery for generation of the novel CHL analogs.
Biosynthesis of the Three-Carbon Unit
Previous biosynthetic studies on the CHL aglycone
demonstrated that the macrolide derives from a single
polyketide chain that contains ten acetates and two pro-
pionates; however, they failed to account for the origin
of the remaining three-carbon (3-C) atoms, C-22, -23,
and -24. Later it was determined that intact isotope-la-
beled glycerol was incorporated into carbon atoms
C-22, -23, and -24, clearly indicating that glycerol serves
as the precursor of the 3-C unit [16]. Of the various me-
tabolites that can derive from glycerol, a few, such as
pyruvate and lactate, were ruled out as intermediate
precursors of the 3-C unit by radioactive tracer experi-
ments, leaving an enoylpyruvate derivative as the most
attractive candidate mechanistically.
Four genes, chlD1, chlD2, chlD3, and chlD4, are sub-
clustered within the CHL cluster, and the deduced func-
tions support their involvement in the biosynthesis of the
3-C unit as outlined in Figure 4C. ChlD1, a FkbH-like pro-
tein, may act on the glycolytic pathway intermediate and
transfer it to the discrete ACP protein ChlD2. ChlD3, theputative dehydratase, assumedly catalyzes 2,3-dehy-
dration and generates enoylpyruvoyl-S-ACP (9). The
chlD3 mutant strain TL1006 lost its CHL productivity
(Figure 2, V), which was then restored by expressing
chlD3 in trans (TL1010, Figure 2, VI), confirming that
ChlD3 is essential for CHL biosynthesis. The final gene,
chlD4, encodes a putative protein that shows homology
to a predicted hydrolase or acyltransferase in Nostoc
punctofome. Inactivation of chlD4 resulted in the CHL-
nonproducing mutant strain TL1007 (Figure 2, X), in
which the CHL production was restored by expressing
chlD4 in trans (TL1011, Figure 2, XI), suggesting that
ChlD4 may catalyze the incorporation of enoylpyruvoyl-
S-ACP into the CHL aglycone (discussed below).
While we have proposed that the CHL 3-C unit forma-
tion starts with glyceroyl-S-ACP (8) that is catalyzed by
the FkbH-like protein ChlD1, 8 could be alternatively
synthesized by ChlM, which is similar to a ketoacyl-
ACP synthase III family. However, inactivation of chlM
retains its CHL productivity upon HPLC analysis, ex-
cluding its involvement in CHL biosynthesis (data not
shown). FkbH homologs have been found in a few
gene clusters of secondary metabolites, such as ansa-
mitocin and FK520 [31, 32]. Although the exact substrate
of FkbH-like protein remains to be determined, its func-
tion has been assigned to catalyze the formation of
methoxymalonyl-S-ACP from a glycolytic pathway inter-
mediate in association with other modification proteins
[33]. Recently, an integrated FkbH domain identified in
the loading module of PKS BryA, presumably responsi-
ble for the initial steps of bryostatin biosynthesis in the
uncultivated marine bacterial symbiont Bugula neritina,
was proposed to catalyze the glyceroyl-S-ACP forma-
tion in the 3-C starter unit biosynthesis [34]. Hence, evi-
dence here supports that the FkbH-like protein ChlD1
serves as the preferred candidate to form 8, which could
represent a common intermediate for incorporation of
the glycerol-derived metabolites into natural product
biosynthesis.
Biosynthesis of Chlorothricolide, 12, the Aglycone
of CHL
Six genes in the CHL cluster, chlA1–chlA6, encode the
multifunctional type I PKSs that consist of a loading mod-
ule and 11 chain-elongation modules, supporting their
roles in the biosynthesis of the chlorothricolide backbone
as outlined in Figure 4D. The modules of ChlA1–A6, com-
prised of the predicted functional domains for chain
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A6 PKSs
(A) Alignments of the conserved motifs of AT
domains from CHL PKSs. Asterisks indicate
the conserved amino acid residues that de-
termine the substrate specificity, and ATs
that activate methylmalonyl-CoA are boxed.
(B) Alignment of the conserved motifs of DH
domains from CHL PKSs. Asterisks indicate
the conserved acidic amino acid residues,
and the putative mutant DH domain of mod-
ule 8 is boxed.extension and modification, are arranged collinear with
their functions in the biosynthetic assembly process.
Each of the modules contains at least three domains of
KS, AT, and ACP that select, activate, and catalyze
a decarboxylative condensation between the extender
unit and the growing polyketide chain, generating a
b-ketoacyl-S-ACP intermediate. Domains DH, enoyl-
reductase (ER) and KR are found between AT and ACP,
which carry out the variable set of reductive modifica-
tions of the b-keto group before the next round of chain
extension [35]. On the basis of sequence analysis, the
substrate specificities of these AT domains were pre-
dicted and fall into two groups (Figure 6A): methylma-
lonyl-CoA for ATs of module 1 and 10, and malonyl-
CoA for ATs of modules 2–9 and 11 as well as the loading
AT domain. An unusual DH domain is identified in module
8 of ChlA4, in which a few acidic amino acid residues
within the conserved motifs shown in Figure 6B, such
as E and D, are replaced by the neutral residues, such
as Q and G, implying that this DH domain could be inac-
tive and its function may not be required during the
eighth round of condensation. The mutant KS domain
(KSQ), which has a glutamine in place of a conserved cys-
teine residue, is found in the loading module, suggesting
that it catalyzes the decarboxylation of malonyl-S-ACP,
which is activated by the loading AT domain, and forms
the acetyl-S-ACP to initiate the elongation process. Con-
sequently, we propose that ChlA1–A6, in a mechanistic
analogy to a number of typical type I PKSs, catalyze
the formation of the nascent tetracosanoyl-S-ACP inter-
mediate (10) via 11 decarboxylation steps in a nonitera-
tive manner.
While 10 is being synthesized, the trans-decalin sys-
tem is proposed to be enantioselectively formed via an
intramolecular [4 + 2] Diels-Alder reaction by addition
of the C-4–C-5 dienophile to the C-10–C-13 diene
(Figure 4D). Catalyzed by the putative acyltransferaseChlD4, the hydroxyl group of enoylpyruvate may serve
as the nucleophile to release the polyketide intermedi-
ate. After the resultant product undergoes a cyclization
reaction to form the characteristic tetranoic acid moiety,
an additional intramolecular [4 + 2] Diels-Alder reaction
could occur by addition of the C-20–C-30dienophile of
the 3-C unit to the C-20–C-23 diene of the polyketide
chain, leading to the formation of the cyclohexene moi-
ety, closing of the macrolide ring, and generation of pre-
chlorothricolide (11, Figure 4D).
Three putative oxidoreductase genes, chlE1, chlE2,
and chlE3, are identified for the postsynthetic modifica-
tion of pre-chlorothricolide or pre-CHL. In contrast to the
aglycone of KIJ or TC-A, which retains the acyltetronic
acid structure, a Baeyer-Villiger oxidation is suggested
to be responsible for converting the acyltetronic acid
into a macrocyclic lactone in the CHL biosynthetic path-
way. Both ChlE1 and ChlE3 resemble a family of FAD-
dependent monooxygenases, implying that one of them
serves as the candidate for catalyzing the Baeyer-
Villiger oxidation reaction. The remaining one, function-
ally associated with ChlE2, which resembles a member
of the P-450 family, may catalyze the oxidation of C-20
methyl branch to a carboxyl group, eventually resulting
in chlorothricolide (12) or CHL (Figure 4D).
While it is proposed that two Diels-Alder reactions
tandemly occurr in chlorothricolide biosynthesis, lead-
ing to the formation of the trans-decalin system and
the cyclohexene moiety, respectively, it remains to be
determined whether these two Diels-Alder reactions
are performed enzymatically or nonenzymatically. The
Diels-Alder reaction, which forms a six-membered ring
from a dienophile and 1,3-diene, is widely applied for
the chemical synthesis of cyclic products with a high
region and stereoselectivity under mild conditions.
Although it has been found to proceed in a number of
biosyntheses of secondary metabolites [36, 37], only
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nonaketide synthase (LNKS) [39], and macrophomate
synthase (MPS) [40], have been characterized as the
natural Diels-Alderases [41], in which no sequence ho-
mology was found. Interestingly, they not only catalyze
the Diels-Alder reaction, but they also have additional
enzymatic activity, such as oxidation, polyketide chain
formation, or decarboxylation. The enzyme converts
the substrate into a reactive intermediate that is not re-
leased from the active site, forcing the intermediate
into a conformation that readily undergoes the Diels-Al-
der reaction, catalyzing the [4 + 2] cycloaddition within
an ‘‘entropy trap’’ [40]. Despite the fact that no obvious
candidates catalyzing the two Diels-Alder reactions
could be identified within the CHL cluster, we propose
that the activities of Diels-Alder reactions might be asso-
ciated with other enzymatic functions of certain proteins
involved in chlorothricolide biosynthesis if it occurs
enzymatically.
Assembly of CHL from D-Olivose, 2-Methoxy-5-
Chloro-6-Methylsalicyclic Acid, and
Chlorothricolide Building Blocks
The CHL molecule could be synthesized by the assem-
bly from the three building blocks: two D-olivoses,
a modified methylsalicyclic acid, and a chlorothricolide
as outlined in Figure 4D. Chlorthricolide may be first gly-
cosylated by two dNDP-D-olivoses at the C-7 hydroxyl
group, which is presumably catalyzed by the putative
glycosyl transferases, ChlC6 and ChlC7. The modified
methylsalicyclic acid could then be transferred to the
C-3 hydroxyl group of the second olivose moiety, which
is likely catalyzed by the putative condensing protein
ChlB6. On the other hand, the assembly process could
begin with pre-chlorothricolide and end with pre-CHL.
If the latter strategy is correct, three modification pro-
teins, CHlE1, ChlE2, and ChlE3, would act on pre-CHL,
eventually converting it into CHL.
Interestingly, according to structural similarities of
aglycones among the spirotetronate antibiotic family,
such as CHL, KIJ, and TC-A, decoration of the aglycones
with various peripheral moieties renders the versatile bio-
logical activities, underscoring nature’s way of combi-
natorial biosynthesis in creating the diversity of struc-
tures and activities of complex natural products.
Significance
The spirotetronate antibiotics, with unique architec-
tures and broad biological activities, have long been
appreciated in the fields of chemistry, biology, and
medical sciences. Decoration of structurally related
aglycones with a variety of peripheral moieties leads
to versatile biological activities, incarnating nature’s
wisdom to create the diversity of structures and activ-
ities of complex natural products via combinatorial
biosynthesis. Here, we report the cloning, sequencing,
and genetic characterization of the CHL biosynthetic
gene cluster from S. antibioticus DSM 40725, and we
provide an assembly model for CHL biosynthesis
from D-olivose, 2-methoxy-5-chloro-6-methylsalicy-
clic acid, and chlorothricolide building blocks. To
our knowledge, this work represents the first cloning
of a gene cluster for spirotetronate antibiotic biosyn-thesis, and it sets the stage for investigating the
unusual macrolide biosynthesis, including tandem
Diels-Alder cyclizations, Baeyer-Villiger oxidation, and
incorporation of an enoylpyruvate unit. Since many
of these proposed enzymes and reactions are novel,
mechanistic characterization of the CHL pathway will
surely make a fundamental contribution to natural
product chemistry and enzymology. The availability
of the CHL biosynthetic gene cluster and its proposed
pathway as a model for spirotetronate antibiotic bio-
synthesis alsomake it possible to apply combinatorial
biosynthesis methods to the CHL biosynthetic ma-
chinery to generate structural diversity.
Experimental Procedures
Bacterial Strains, Plasmids, and Reagents
Bacterial strains and plasmids used in this study are summarized in
Table S1. Biochemicals, chemicals, media, restriction enzymes, and
other molecular biological reagents were obtained from standard
commercial sources.
DNA Isolation, Manipulation, and Sequencing
DNA isolation and manipulation in E. coli and Streptomyces were
carried out according to standard methods [42, 43]. PCR amplifica-
tions were carried out on an Authorized Thermal Cycler (Eppendorf
AG 22331; Hamburg, Gemany) with either Taq DNA polymerase or
PfuUltra High-Fidelity DNA polymerase. For the NGDH gene,
a 0.55 kb internal fragment was obtained by two-stage PCR amplifi-
cation: a distinct 1.0 kb fragment amplified from the genomic DNA of
S. antibioticus DSM 40725 by using primers 50-GATGAATTCATG
AACCTCCTCGTCACC-30 and 50-CGGAAGCTTTCAGCCATCGCG-
30 [18] was purified and directly used as the template for the second-
ary amplification by using the degenerated pair of primers 50-
CSGGSGSSGCSGGSTTCATSGG-30 and 50-GGGWRCTGGYRSGGS
CCGTAGTTG-30 [44]. The identity of the PCR product as oxiIII was
further confirmed by sequencing. For P1 and P2, a 0.75 kb fragment
was amplified by PCR by using the following pair of degenerate
primers: 50-GGCCGGGCCTTCCAGGACSNSGGSNTSRACTC-30 (de-
signed according to the conserved motif of ACP domains of type I
PKSs: GRASRDXGXD/NS) and 50-CGCCAGGTGCATCGCCACSAR
SGASGASGARCA-30 (designed according to the conserved motif
of KS domains of type I PKSs: CSSSLVAMHLA). For P4, a 500 bp
fragment was amplified by PCR by using the following pair of
primers: 50-TCGTGGGTGCGCGCGATG-30 and 50-CGGAAACCGAG
CAGTCCG-30. The amplification of P3 was described (L.S. et al.,
unpublished data). Primer synthesis and DNA sequencing were per-
formed at the Shanghai GeneCore Biotechnology, Inc. and the
Chinese National Human Genome Center.
Genomic Library Construction and Screening
A genomic library of S. antibioticus DSM 40725 was constructed in
Super-Cos1 according to standard protocols [43]. Escherichia coli
XL1-Blue MRF and Gigapack III XL packaging extract (Stratagene,
La Jolla, CA) were used for library construction according to the
manufacture’s instructions. The genomic library (6000 colonies)
was screened by colony hybridization with the PCR-amplified prod-
ucts P1, P2, P3, or P4 as a probe, and resultant positive clones were
further confirmed by Southern hybridization.
Sequence Analysis
The orfs were deduced from the sequence by using the FramePlot
3.0b program (http://watson.nih.go.jp/wjun/cgi-bin/frameplot-3.
0b.pl). The corresponding deduced proteins were compared with
other known proteins in the databases by using available BLAST
methods (http://www.ncbi.nlm.nih.gov/blast/). Amino acid se-
quence alignments were performed by using the CLUSTALW method
as well as by using the DRAWTREE and DRAWGRAM methods from
BIOLOGYWORKBENCH 3.2 software (http://workbench.sdsc.edu).
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Introduction of plasmid DNA intoS. antibioticusDSM 40725 was car-
ried out by either polyethylene glycol (PEG)-mediated protoplast
transformation or E. coli-S. antibioticus DSM 40725 conjugation,
by following the procedure described previously [44].
The constructs for gene inactivation and complementation used in
this study are summarized in Supplemental Data.
The constructs for gene inactivation were introduced into S. anti-
bioticus DSM 40725. For gene disruption, colonies that were apra-
mycin resistant at 37ºC were identified as the mutants. For gene re-
placement, colonies that were apramycin resistant and thiostrepton
sensitive at 37ºC were identified as the mutants, each of which has
also been complemented by expressing the target gene in trans un-
der the control of the ermE* promoter. The genotypes of the mutant
strains were confirmed by Southern hybridization (Supplemental
Data). Recombinant strains were cultured and analyzed for CHL
production by HPLC with the S. antibioticus DSM 40725 wild-type
strain as a control.
Production, Isolation, and Analysis of CHL
S. antibioticus DSM 40725 wild-type and recombinant strains were
grown on R2YE agar plates (with appropriate antibiotic for recombi-
nant strains) at 30ºC for sporulation and CHL production on solid
agar. For fermentation in liquid culture, 100 ml spore suspension
(cfu 5.2 3 106 cells/ml) of the S. antibioticus DSM 40725 strain was
inoculated into 50 ml seed medium (Soybean meal 2%, Mannitol
2%, and CaCO3 0.2%) in a 250 ml flask and incubated at 30ºC and
240 rpm for 2 days. A total of 2.5 ml seed culture was transferred
into 100 ml of the same medium in a 500 ml flask and incubated at
30ºC and 240 rpm for 3 days.
For CHL or DM-CHL isolation from solid agar, each 20 ml of culture
(R2YE agar plate) of S. antibioticus DSM 40725 strain was freeze
dried, homogenized, and fragmented by ultrasound, and then ex-
tracted twice with 50 ml methanol. After the precipitate was
removed, the combined extract was concentrated in a vacuum
and resolved in 1 ml methanol. For CHL isolation from liquid culture,
each 20 g mycelia collected by centrifuging was washed with water,
lyophilized in a vacuum, and fragmented by ultrasound. A total of 10
g freeze-dried mycelia was extracted twice with 50 ml methanol, and
the combined extract was concentrated and adjusted to a pH of
5.0 after addition of an equal volume of water. After it was extracted
three times with ethyl acetate, the combined mixture was dried with
MgSO4, evaporated to dryness, and then resolved in 1 ml methanol.
HPLC analysis of CHL was carried out on a Nova-Pak C18 column
(3.93 150 mm, Part No. WAT086344, Waters Corp., Ireland). The col-
umn was equilibrated with 50% solvents A (H2O, 0.05% TFA) and B
(CH3CN, 0.05% TFA) and was developed with the following program:
0–5 min, 60% A/40% B; 5–20 min, a linear gradient from 60% A/40%
B to 15% A/85% B; 20–25 min, constant 15% A/85% B; 25–30 min,
a linear gradient from 15% A/85% B to 60% A/40% B. This was car-
ried out at a flow rate of 1 ml/min and UV detection at 222 nm by
using an Agilent 1100 HPLC system (Agilent Technologies. Palo
Alto, CA). The identity of the compound was confirmed by liquid
chromatography-mass spectrometry (LC-MS) analysis performed
on LCMS-2010 A (Liquid Chromatograph Mass Spectrometer,
SHIMADZU, JP). The CHL and deschloro-CHL showed an (M-H)2
ion at m/z = 953.0 and m/z = 919.0, consistent with the molecular for-
mula C50H63ClO16 and C50H64O16, respectively. NMR spectra were
measured on a Varian Inova 600 (600 MHz) spectrometer (Supple-
mental Data).
Bioassay of CHL and DM-CHL
To detect the biological activities of CHL and DM-CHL against
B. subtilis, each 20 ml methanol extract from solid agar described
above was added to the roundness filter paper that was placed on
LB agar preseeded with an overnight B. subtilis culture. The plate
was incubated at 37ºC for 24 hr, and the biological activity was esti-
mated by measuring the sizes of the inhibition zones.
Supplemental Data
Supplemental Data include bacterial strains and plasmids in this
study, constructs for gene inactivation and complementation,
Southern hybridization analysis of mutant strains, and chemicalstructural elucidation of Dm-CHL and are available at http://www.
chembiol.com/cgi/content/full/13/6/575/DC1/.
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